Schwartz Center Receives $500,000 Grant from the Amgen Foundation

AmgenThe Schwartz Center for Compassionate Healthcare, a Boston-based nonprofit dedicated to strengthening the relationship between patients and their healthcare providers, today announced it has received a $500,000 grant from the Amgen Foundation. This grant will go toward the planned expansion of Schwartz Center Rounds® and to support the launch of a National Consensus Project.

These initiatives aim to make compassionate, patient-centered care a national healthcare priority. The Schwartz Center Rounds allow caregivers from multiple disciplines to come together on a regular basis to discuss the most challenging emotional and social issues they face in caring for patients. The National Consensus Project will convene a broad range of stakeholders to define compassionate care, develop best practices to ensure that this type of care is provided, and develop a plan to implement these core principles and best practices.

"This grant, the largest in our history, will make it possible for us to double the number of Rounds sites overall in California and the Washington, D.C. area and to expand the program to additional cancer centers throughout the United States," said Julie Rosen, executive director, Schwartz Center. "It will also allow us to launch our National Consensus Project to ensure that all patients receive compassionate care something that is particularly important now as our healthcare system is changing and providers are under such intense pressure to reduce costs, while improving quality."

The Amgen Foundation, based in Thousand Oaks, is the philanthropic arm of Amgen, the world's largest biotechnology company. A key area of focus for the Foundation is ensuring quality of care and access for patients with an emphasis on patient empowerment and reducing healthcare disparities.

"The Schwartz Center provides health professionals with a practical avenue to reflect upon and manage through the complexities inherent in providing care for seriously ill patients," said Jean Lim Terra, president, Amgen Foundation. "We are proud to support these programs that empower healthcare professionals to truly fulfill their mission to deliver quality care for patients."

Schwartz Center Rounds are currently held at 247 hospitals and other healthcare institutions in 35 states in the United States (U.S.) and at 11 hospitals in the United Kingdom. A comprehensive evaluation has shown that caregivers who attend multiple Rounds sessions feel more compassionate toward their patients and less stressed. Attendees also report that the program has improved teamwork and resulted in system changes.

Through its National Consensus Project, the Schwartz Center will launch a national conversation about the importance of compassionate care by convening healthcare professionals, patients, policymakers, educators and researchers to reach expert consensus on a definition of compassionate care, develop a set of organizational and institutional best practices to ensure that this type of care is provided, and develop a plan for disseminating these core principles and best practices.

According to Rosen, "Our vision is a healthcare system in which all patients receive compassionate, patient- and family-centered care, and all caregivers are supported to provide it. We are grateful to the Amgen Foundation for helping us to make this vision a reality."

The Schwartz Center's vision is based on the experience of Ken Schwartz, a well-known Boston healthcare attorney who died of lung cancer at the age of 40 and found that what mattered to him most as a patient was the compassionate care he received from his caregivers, which he wrote in the Boston Globe Magazine "made the unbearable bearable." He founded the Schwartz Center in 1995 to ensure that all patients receive compassionate care.

In a national survey conducted by the Schwartz Center in 2010, more than 80 percent of patients said they believe that effective communication and emotional support the essential elements of compassionate care make a difference in how well patients recover from illness and can even make a difference in whether a patient lives or dies. Yet, patients' ratings of how well their caregivers demonstrated these attributes fell short of their expectations and only about half of patients rated the U.S. healthcare system as a compassionate one.

The Amgen Foundation has been a long-time supporter of the Schwartz Center, having previously provided financial support for Schwartz Center Rounds in 2004 and then again in 2009.

About the Amgen Foundation
The Amgen Foundation seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made nearly $180 million in grants to local, regional, and national nonprofit organizations that impact society in inspiring and innovative ways. It has also supported disaster relief efforts both domestically and internationally.

About the Schwartz Center for Compassionate Healthcare
The Schwartz Center is a national nonprofit organization that develops and funds innovative programs to promote compassionate care, recognizes and honors caregivers who demonstrate extraordinary compassion in caring for patients and families, and supports policies that promote compassionate care. Its "Agenda for Improving Compassionate Care" was published in the September 2010 issue of Health Affairs, the nation's leading health policy journal. The Center is housed at Massachusetts General Hospital in Boston.

Most Popular Now

Fasenra (benralizumab) receives US FDA approval fo…

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab)...

A great place to do great things: Developing game-…

Science has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world. For the 14th year, the journal Science today recognized...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

New tissue-engineered blood vessel replacements on…

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doe...

China's out of control 'silent killer' affects one…

More than one-third of adults in China have high blood pressure - often dubbed the "silent killer" for its lack of symptoms - but only about one in 20 have the condition ...

MSD Innovation Factory is looking for digital solu…

MSD is looking for innovators to solve 7 health-related challenges. One of them seeks to support anaesthesiologists with their continuous education (e.g. at the operation...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]